Mary Mosher

Array ( [id] => 4338890 [patent_doc_number] => 06333395 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Compositions for inhibition of membrane fusion-associated events, including human parainfluenza virus transmission' [patent_app_type] => 1 [patent_app_number] => 8/474349 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 84 [patent_no_of_words] => 88537 [patent_no_of_claims] => 107 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333395.pdf [firstpage_image] =>[orig_patent_app_number] => 474349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1569641 [patent_doc_number] => 06497882 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Recombinant swinepox virus' [patent_app_type] => B1 [patent_app_number] => 08/472679 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 114 [patent_figures_cnt] => 114 [patent_no_of_words] => 87603 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/497/06497882.pdf [firstpage_image] =>[orig_patent_app_number] => 08472679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3835139 [patent_doc_number] => 05744142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Self-assembling recombinant papillomavirus capsid proteins' [patent_app_type] => 1 [patent_app_number] => 8/475782 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8815 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744142.pdf [firstpage_image] =>[orig_patent_app_number] => 475782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811153 [patent_doc_number] => 05770211 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease' [patent_app_type] => 1 [patent_app_number] => 8/480210 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 30 [patent_no_of_words] => 6451 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770211.pdf [firstpage_image] =>[orig_patent_app_number] => 480210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 723323 [patent_doc_number] => 07045136 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-16 [patent_title] => 'Methods of immunization using recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences' [patent_app_type] => utility [patent_app_number] => 08/470359 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14929 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045136.pdf [firstpage_image] =>[orig_patent_app_number] => 08470359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 757369 [patent_doc_number] => 07015024 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-21 [patent_title] => 'Compositions containing recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences' [patent_app_type] => utility [patent_app_number] => 08/470357 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14920 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015024.pdf [firstpage_image] =>[orig_patent_app_number] => 08470357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257072 [patent_doc_number] => 06204044 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines' [patent_app_type] => 1 [patent_app_number] => 8/465747 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5414 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204044.pdf [firstpage_image] =>[orig_patent_app_number] => 465747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7609934 [patent_doc_number] => 06998252 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-14 [patent_title] => 'Recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences' [patent_app_type] => utility [patent_app_number] => 08/470360 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14676 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998252.pdf [firstpage_image] =>[orig_patent_app_number] => 08470360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3607432 [patent_doc_number] => 05589377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Recombinant adeno-associated virus vectors' [patent_app_type] => 1 [patent_app_number] => 8/490095 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8464 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589377.pdf [firstpage_image] =>[orig_patent_app_number] => 490095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774396 [patent_doc_number] => 05756670 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Method and means for producing an immunoglobulin-binding protein' [patent_app_type] => 1 [patent_app_number] => 8/467172 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 6330 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756670.pdf [firstpage_image] =>[orig_patent_app_number] => 467172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4233678 [patent_doc_number] => 06143493 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'HCMV-specific peptides, agents therefor and the use thereof' [patent_app_type] => 1 [patent_app_number] => 8/462211 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11346 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 167 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143493.pdf [firstpage_image] =>[orig_patent_app_number] => 462211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3905757 [patent_doc_number] => 06001371 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Parvovirus capsids' [patent_app_type] => 1 [patent_app_number] => 8/462464 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 6919 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001371.pdf [firstpage_image] =>[orig_patent_app_number] => 462464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1387651 [patent_doc_number] => 06541009 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Viral vaccines' [patent_app_type] => B1 [patent_app_number] => 08/462632 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 7284 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541009.pdf [firstpage_image] =>[orig_patent_app_number] => 08462632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795462 [patent_doc_number] => 05827647 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-27 [patent_title] => 'Parvovirus capsids' [patent_app_type] => 1 [patent_app_number] => 8/463332 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 29 [patent_no_of_words] => 6921 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/827/05827647.pdf [firstpage_image] =>[orig_patent_app_number] => 463332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825045 [patent_doc_number] => 05759814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Expression of recombinant glycoprotein B from herpes simplex virus' [patent_app_type] => 1 [patent_app_number] => 8/465467 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 21 [patent_no_of_words] => 15303 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759814.pdf [firstpage_image] =>[orig_patent_app_number] => 465467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636770 [patent_doc_number] => 06379885 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines' [patent_app_type] => B1 [patent_app_number] => 08/465557 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5422 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379885.pdf [firstpage_image] =>[orig_patent_app_number] => 08465557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636770 [patent_doc_number] => 06379885 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines' [patent_app_type] => B1 [patent_app_number] => 08/465557 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5422 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379885.pdf [firstpage_image] =>[orig_patent_app_number] => 08465557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4367116 [patent_doc_number] => 06287815 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines' [patent_app_type] => 1 [patent_app_number] => 8/461988 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5392 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287815.pdf [firstpage_image] =>[orig_patent_app_number] => 461988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 856394 [patent_doc_number] => 07374768 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-05-20 [patent_title] => 'Viral vaccines' [patent_app_type] => utility [patent_app_number] => 08/459040 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 43 [patent_no_of_words] => 18874 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/374/07374768.pdf [firstpage_image] =>[orig_patent_app_number] => 08459040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790650 [patent_doc_number] => 05780280 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Recombinant adeno-associated virus vectors' [patent_app_type] => 1 [patent_app_number] => 8/459352 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8409 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780280.pdf [firstpage_image] =>[orig_patent_app_number] => 459352 [rel_patent_id] =>[rel_patent_doc_number] =>)